One of the secrets of the stock market is that opportunities often arise from unexpected downturns. As we navigate the complex landscape of 2023, market corrections unveil a unique silver lining for astute investors that are willing to take a risk with falling stocks to buy.
In this article, we delve into the art of identifying and capitalizing on stocks that have weathered a significant dip, transforming temporary setbacks into compelling investment prospects. These market corrections present a paradoxical playground for those with a keen eye for value.
When stock prices plummet, valuations often overshoot to the downside, creating an environment where the discerning investor can uncover hidden gems. This counterintuitive strategy involves seeking out companies whose fundamentals remain robust despite short-term market turbulence.
By strategically navigating this terrain, investors can position themselves to ride the wave of recovery, turning falling stocks to buy into pillars of a resilient portfolio.
Join us as we explore the rationale behind this approach and unveil potential opportunities for savvy traders in the ever-evolving landscape of 2023.Top of Form
Today’s Top Losers on Nasdaq
The five stocks listed below have recently experienced a decline in their prices, rendering them particularly appealing from a valuation perspective, especially considering their robust fundamentals.
These falling stocks to buy present promising opportunities for investors to capitalize on the market dip and acquire assets with strong underlying financial foundations:
-
Coherus BioSciences
Coherus BioSciences Inc. (NASDAQ: CHRS) presents a compelling buying opportunity amidst its recent stock dip to the territory of top 10 worst stocks today.
The company boasts a robust portfolio with six biosimilar products, including a Humira biosimilar sold at an 85% discount.
Despite a temporary setback for Udenyca, a pegfilgrastim biosimilar, the FDA re-submission signals a positive trajectory, even though CHRS has dropped by 76% since the start of the year.
Revenue from existing products surged by 64%, with a mere $250 million guidance for 2023, yet the stock trades at a meager enterprise value of $260 million, yielding an EV/sales ratio of 1 – an astonishing bargain compared to industry averages.
Toripalimib’s recent FDA approval in nasopharyngeal cancer adds significant value, potentially contributing $10 per share.
With an impressive leadership team, a healthy balance sheet, and technical indicators suggesting a trend reversal, Coherus BioSciences is undervalued.
Despite associated risks, the stock seems to be prudent for savvy investors, among falling stocks to buy.
-
Tesla
Tesla, Inc. (NASDAQ: TSLA) presents a compelling buying opportunity amidst its recent 20% dip, since July. The key attraction lies in its currently discounted valuation, particularly after the Q3 earnings revealed a temporary gross margin setback at 17.9%.
Investors became concerned earlier this year, when the stock made it among the biggest Nasdaq stock losers today. Critics emphasize heightened competition, Elon Musk’s various ventures, and a perceived high valuation.
However, this dip is driven by transient factors, including price cuts to stimulate demand, which, coupled with renewed federal tax credits, creates an enticing buyer’s market.
Tesla’s expansive Supercharger network, now open to non-Tesla EVs, signals broader revenue streams.
Moreover, with a diversified portfolio encompassing solar, robotics, and ambitious EV models like the Cybertruck, Tesla’s long-term prospects remain robust.
Despite short-term challenges, Tesla’s multi-faceted growth narrative, dominance in EV infrastructure, and commitment to sustainability position it as a compelling buy, even at a P/E of 56x in a 5%+ interest rate environment.
This dip is a strategic entry point for investors eyeing substantial future gains, among the top falling stocks to buy
-
T.Rowe Price Group Inc.
T.Rowe Price Group (NASDAQ: TROW) presents a compelling buying opportunity amidst a challenging market period.
With TROW shares down 53% since their peak in August 2021, the stock’s current valuation is notably attractive. There is some strong momentum here which could position TROW among biggest stock gainers today.
As a stalwart in asset management, TROW manages a substantial $1.4 trillion in assets, ranking 16th globally.
Despite recent outflows, the company’s historical track record, with 71% of composites outperforming benchmarks over the past decade, establishes a robust competitive advantage.
TROW’s sound financial position, boasting $2.25 billion in cash, zero debt, and shareholder-friendly capital allocation, further strengthens its appeal.
Trading at 12.1x earnings, a significant discount to the S&P 500, and offering a 5.08% yield, TROW is positioned as a prudent investment, particularly considering its potential as an M&A target in a consolidating industry.
TROW stands as a very compelling pick with its resilient fundamentals and attractive valuation.
-
Toast Inc.
Toast (NYSE: TOST) presents a compelling buying opportunity after a recent 20% dip post-Q3 earnings. Despite a modest adjustment in full-year revenue outlook, the market reaction seems exaggerated.
With a tightened FY23 revenue projection of $3.83-$3.86 billion, implying 40-41% YoY growth, Toast remains on a robust trajectory. Notably, the CEO transition to Aman Narang is a seamless shift, minimizing disruption.
Toast’s strategic evolution beyond a Point of Sale (PoS) system to a comprehensive restaurant management platform is a key long-term driver.
With a mere 10% penetration in U.S. restaurants and a Total Addressable Market (TAM) of $110 billion, Toast’s growth prospects are vast.
The recent crash appears disproportionate to its healthy growth and expanding margins, making it an opportune moment for investors to capitalize on this market overreaction.
Stay bullish, and consider leveraging this dip to bolster your position. TOST is definitely an interesting pick for traders who closely watch top losers and gainers.
-
Boyd Gaming Corp.
Boyd Gaming Corp. (NYSE: BYD) presents a compelling investment opportunity as its stock currently trades below $60, offering an attractive entry point. Despite a temporary dip from its July high of $72, BYD’s fundamentals remain robust.
The 3Q23 performance showcased resilience in revenue, with $903 million, up from $877 million year-over-year. With a trailing twelve months P/E of 8.78, significantly lower than competitors like Red Rock Resorts (RRR) at 12.81, BYD is undervalued.
The recent acquisition of B2B Pala Interactive for $170 million positions BYD strongly in the digital gaming space. Furthermore, the upcoming Flutter Entertainment Ltd. (FLTR”L) NYSE listing, where BYD holds 5% equity, is anticipated to boost valuation.
Considering BYD’s strategic moves, diversified footprint, and transactional prowess, the current dip appears as a buying opportunity with a revised price target of $75 by 1Q24.
Frequently Asked Questions
Why Should I Consider Investing in Stocks During a Market Downturn?
Opportunities often arise from unexpected downturns, unveiling a unique silver lining for astute investors who can capitalize on undervalued stocks with robust fundamentals.
How To Find Potential Investments During a Market Correction?
Look for companies whose fundamentals remain strong despite short-term market turbulence, as valuations tend to overshoot to the downside, creating opportunities for discerning investors.
Is It Wise to Invest in A Company Like Coherus Biosciences?
Yes, despite a temporary setback, Coherus BioSciences presents a compelling buying opportunity with a robust portfolio, impressive leadership, and technical indicators suggesting a trend reversal.
Why Consider Tesla for Investment?
Tesla’s dip is driven by transient factors, including price cuts and heightened competition, making it an enticing buyer’s market. Its diversified portfolio and commitment to sustainability position it for substantial future gains.
What Makes T. Rowe Price Group an Attractive Investment?
With a historical track record of outperforming benchmarks, a sound financial position, and an attractive valuation, T. Rowe Price Group is a prudent investment, especially considering its potential as an M&A target.
Should I Be Concerned About Toast’s Recent Dip?
No, the market reaction seems exaggerated, and Toast’s strategic evolution beyond a Point of Sale system positions it for long-term growth. Consider leveraging this dip to bolster your position.
Why Is Boyd Gaming Corp. Considered A Compelling Investment?
Despite a temporary dip, Boyd Gaming Corp.’s fundamentals remain robust, with strong revenue performance and strategic moves in the digital gaming space. The current dip presents a buying opportunity with a revised price target of $75 by 1Q24.
What Factors Contribute to T. Rowe Price Group’s Appeal?
T. Rowe Price Group’s sound financial position, historical outperformance, and attractive valuation make it an appealing target in a consolidating industry, enhancing its investment appeal.
Is Tesla’s Current Valuation Justified?
Tesla’s current dip is driven by transient factors, and its multi-faceted growth narrative, dominance in EV infrastructure, and commitment to sustainability justify its valuation, especially for investors eyeing substantial future gains.
Why Is Toast Considered a Compelling Long-Term Investment?
Toast’s strategic evolution and strong growth prospects, with a modest adjustment in full-year revenue outlook, make it a compelling long-term investment. The recent market overreaction provides an opportune moment for investors.
